A novel approach to the psychopharmacologic treatment of insomnia in depression

Medical Hypotheses

Volumn 63, Issue 1, 2004, Pages 26-30

  Boyle, Aelred ^a  

^a Lincoln Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CLONAZEPAM; ETIRACETAM; GABAPENTIN; INSULIN; INTERFERON; LAMOTRIGINE; LITHIUM; METHADONE; NEFAZODONE; OXCARBAZEPINE; PAROXETINE; PHENYTOIN; RISPERIDONE; SERTRALINE; TIAGABINE; TOPIRAMATE; TRAZODONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZALEPLON; ZOLPIDEM;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DEPRESSIVE PSYCHOSIS; DISSOCIATIVE DISORDER; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL REFLUX; GRAND MAL EPILEPSY; HEPATITIS C; HUMAN; HYPOMANIA; INSOMNIA; INSULIN DEPENDENT DIABETES MELLITUS; LOW BACK PAIN; MAJOR DEPRESSION; MALE; MANIA; NAUSEA; PANIC; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SUSTAINED DRUG RELEASE;

ADULT; AGED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 3042804933     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.02.012     Document Type: Article

References (26)

1. Landi F., Cesari M., Russo A., Onder G., Sgadari A., Bernabei R. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Clin Pharmacol Ther. 72(6):2002;729-734
2. Ghaemi S.N., Ko J.Y., Goodwin F.K. "Cade's disease" and beyond: misdiagnosis, anti-depressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 47(2):2002;125-134
3. Post R.M. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anti-convulsant carbamazepine. Pharmacopsychiatry. 23(1):1990;3-17
4. Goddard G.V. Development of epileptic seizures through brain stimulation at low intensity. Nature. 214:1967;1020-1021
5. The Practitioner 1907;1:166, as quoted in Squires' Companion to British Pharmacopoeia 1908, as quoted in Cade, op cit
6. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Loiseau P., Perucca E. Progress report on new anti-epileptic drugs: a summary of the fourth Eilat conference (EILAT IV). Epilepsy Res. 34(1):1999;1-41
7. Maidment I.D. Gabapentin treatment for bipolar disorders. Ann Pharmacother. 35(10):2001;1264-1269
8. Karam-Hage M., Brower K.J. Gabapentin treatment for insomnia associated with alcohol dependence. Am J Psychiatry. 157(1):2000;151-152
9. Leadbetter R., Messenheimer J., Bentley B., Greene P., Huffman R., Spaulding T. Mood-stabilizing properties of Lamotrigine: a review of data from controlled clinical trials. Psychiat Ann. 32(12):2002;766-772
10. Noyer M., Gillard M., Matagne A., et al. The novel anti-epileptic drug levetiracetam (ucb LO59) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol. 286:1995;137-146
11. Lukyanetz E.A., Shkryl V.M., Kostyuk P.G. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia. 43(1):2002;9-18
12. Niespodziany I., Klitgaard H., Margineau D.G. Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices. Neurosci Lett. 306:2001;5-8
13. Rigo J.M., Hans G., Ngyuen L., et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Brit J Pharmacol. 136(5):2002;659-672
14. Post R.M., Ketter T.A., Denicoff K., Pazzaglia P.J., Leverich G.S., Marangell L.B., et al. The place of anti-convulsant therapy in bipolar illness. Psychopharmacology. 128(2):1996;115-129
15. Borden L.A., Murali Dhar T.G., Smith K.E., Weinshark R.L., Branchek T.A., Gluchowski C. Tiagabine, SK & F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol. 269(2):1994;219-224
16. Mathias S., Wetter T.C., Steiger A., Lancel M. The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects. Neurobiol Aging. 22(2):2001;247-253
17. Suppes T. Review of the use of topiramate for treatment of bipolar disorders. J Clin Psychiatry. 22(6):2002;599-609
18. Loscher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 16(10):2002;669-694
19. Guimbal C., Klostermann A., Kilimann M.W. Phylogenetic conservation of 4-aminobutyric acid (GABA) transporter isoforms. Cloning and pharmacological characterization of a GABA/β-alanine transporter from Torpedo. Eur J Biochem. 234(3):1995;794-800
20. Chang L., Cloak C., Ernst T. Magnetic Resonance Spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry. 64(Suppl 3):2003;7-14
21. Judd L.L., Akiskal H.S. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disorders. 73(1-2):2003;123-131
22. Cade, John FJ. Lithium salts in the treatment of psychotic excitement. Med J Australia 1949;2:349-352. Reprinted in Mitchell PB, Hadzi-Pavlovic D. Bull World Health Organ 2000;78(4):518-520
23. Cade, John FJ. Lithium salts in the treatment of psychotic excitement. Med J Australia 1949;2:349-352. Reprinted in Mitchell PB, Hadzi-Pavlovic D. Bull World Health Organ 2000;78(4):518-520
24. Wehr T.A., Goodwin F.K. Rapid cycling in manic-depressives induced by tricyclic anti-depressants. Arch Gen Psychiat. 36(5):1979;555-559
25. Ghaemi S.N., Boiman E.E., Goodwin F.K. Diagnosing bipolar disorder and the effect of anti-depressants: a naturalistic study. J Clin Psychiatry. 61(10):2000;804-809
26. Zis A.P., Goodwin F.K. Major affective disorder as a recurrent illness: a critical review. Arch Gen Psych. 36(8 spec no):1979;835-839